Comportement des formations élastiques gingivales dans la maladie parodontale = Behavior of gingival elastic constituents in periodontal diseaseBONNAURE-MALLET, M; APIOU, J; CHAMBON, Y et al.Pathologie et biologie. 1991, Vol 39, Num 1, pp 42-46, issn 0369-8114Article

The pharmacokinetics and acute renal effects of oral microemulsion ciclosporin A in normal pigsCIBULSKYTE, Donata; PEDERSEN, Michael; HJELM-POULSEN, Jørgen et al.International immunopharmacology. 2006, Vol 6, Num 4, pp 627-634, issn 1567-5769, 8 p.Article

Escleroderma y ciclosporina A^*BORREGO, L; RUIZ, R; DE PABLO, P et al.Actas dermo-sifiliográficas (Ed. impresa). 1992, Vol 83, pp 76-80, issn 0001-7310, NSArticle

Cyclosporin A: immune suppressant and antiparasitic agentTHOMSON, A. W; SMITH, S. W. G; CHAPPELL, L. H et al.Parasitology today (Regular ed.). 1986, Vol 2, Num 10, pp 288-290, issn 0169-4758Article

Neue Immunsuppressiva in der Therapie der Psoriasis : Psoriasis = New immunosuppressive agents for treating psoriasis : PsoriasisORTIZ-URDA, S; RAPPERSBERGER, K.Hautarzt. 2003, Vol 54, Num 3, pp 230-236, issn 0017-8470, 7 p.Article

Explaining variability in ciclosporin exposure in adult kidney transplant recipientsPRESS, Rogier R; PLOEGER, Bart A; DEN HARTIGH, Jan et al.European journal of clinical pharmacology. 2010, Vol 66, Num 6, pp 579-590, issn 0031-6970, 12 p.Article

Effects of ciclosporin A, tacrolimus and sirolimus on cytokine production in neonatal immune cellsPUZIK, Alexander; SCHULTZ, Christian; IBIHER, Peter et al.Acta paediatrica (Oslo). 2007, Vol 96, Num 10, pp 1483-1489, issn 0803-5253, 7 p.Article

The effects of berberine on the pharmacokinetics of ciclosporin a in healthy volunteersXIN, H.-W; WU, X.-C; LI, Q et al.Methods and findings in experimental and clinical pharmacology. 2006, Vol 28, Num 1, pp 25-29, issn 0379-0355, 5 p.Article

Effects of cyclosporin A on refractory B-cell chronic lymphocytic leukemiaNISHII, K; KATAYAMA, N; MITANI, H et al.International journal of hematology. 2000, Vol 71, Num 1, pp 59-65, issn 0925-5710Article

Nuestra experiencia en el tratamiento de la psoriasis con ciclosporina A^* en el Hospital Universitario de CanariasNODA, A; SANCHEZ, R; THEIS, E. G et al.Actas dermo-sifiliográficas (Ed. impresa). 1992, Vol 83, pp 25-29, issn 0001-7310, NSArticle

Respuesta al tratamiento prolongado con dosis bajas de ciclosporina A^* en psoriasisTOMAS, G; SANCHEZ, J; RODRIGUEZ, T et al.Actas dermo-sifiliográficas (Ed. impresa). 1992, Vol 83, pp 33-35, issn 0001-7310, NSArticle

Cross-reactivities of cyclosporin G (NVa²-cyclosporin) and metabolites in cyclosporin A immunoassaysYATSCOFF, R. W; LANGMAN, L. J; LEGATT, D. F et al.Clinical chemistry (Baltimore, Md.). 1993, Vol 39, Num 6, pp 1089-1092, issn 0009-9147Conference Paper

Cytotoxic effects of cyclosporin a on the exocrine pancreas in ratsHIRANO, T; MANABE, T; PRINTZ, H et al.Surgery, gynecology & obstetrics. 1992, Vol 175, Num 6, pp 495-500, issn 0039-6087Article

Perfil de seguridad de Ciclosporina A^*: orientaciones para el uso de ciclosporina en la psoriasisLABURTE, C.Actas dermo-sifiliográficas (Ed. impresa). 1992, Vol 83, pp 16-20, issn 0001-7310, NSArticle

Pioderma gangrenoso. Respuesta al tratamiento con ciclosporina A^* en una serie de cinco casosPLANAGUMA, M; PUIG, L; GARCIA-PATOS, V et al.Actas dermo-sifiliográficas (Ed. impresa). 1992, Vol 83, pp 68-70, issn 0001-7310, NSArticle

Mecanismo de acción y bases para el empleo de la ciclosporina A^* en la psoriasisBOREL, J. F.Actas dermo-sifiliográficas (Ed. impresa). 1992, Vol 83, pp 2-7, issn 0001-7310, NSArticle

Ciclosporina A^* oral en el tratamiento de la psoriasis severa. Estudio clínico e inmunohistoquímico de trece pacientesDAUDEN, E; FERNANDEZ, K; RIOS, L et al.Actas dermo-sifiliográficas (Ed. impresa). 1992, Vol 83, pp 53-58, issn 0001-7310, NSArticle

Tratamiento de la dermatitis actínica crónica con ciclosporina A^* más PUVA: a propósito de dos casosEIZAGUIRRE, X; GARDIAZABAL, J; ARREGUI, M. A et al.Actas dermo-sifiliográficas (Ed. impresa). 1992, Vol 83, pp 81-84, issn 0001-7310, NSArticle

Brequinar sodium (Dup 785) is a highly potent antimetabolite immunosuppressant that suppresses heart allograft rejectionMURPHY, M. P; MORRIS, R. E.Medical science research. 1991, Vol 19, Num 24, pp 835-836, issn 0269-8951Article

Significance of cyclosporin-A-associated renal surface irregularitiesCORNISH, J; VANDERWEE, M; FINDON, G et al.British journal of experimental pathology. 1988, Vol 69, Num 6, pp 839-844, issn 0007-1021Article

Enjuagues orales con ciclosporina A^* a bajas dosis en el tratamiento del liquen plano erosivoALEGRE, V; BOTELLA-ESTRADA, R; SANMARTIN, O et al.Actas dermo-sifiliográficas (Ed. impresa). 1992, Vol 83, pp 71-72, issn 0001-7310, NSArticle

Efectos colaterales renales de la ciclosporina A^*MASON, J.Actas dermo-sifiliográficas (Ed. impresa). 1992, Vol 83, pp 21-24, issn 0001-7310, NSArticle

The NMR structure of cyclosporin A bound to cyclophilin in aqueous solutionWEBER, C; WIDER, G; VON FREYBERG, B et al.Biochemistry (Easton). 1991, Vol 30, Num 26, pp 6563-6574, issn 0006-2960Article

Cyclosporin A in combination with photochemotherapy (PUVA) in the treatment of psoriasisPETZELBAUER, P; HOÊNIGSMANN, H; LANGER, K et al.British journal of dermatology (1951). 1990, Vol 123, Num 5, pp 641-647, issn 0007-0963, 7 p.Article

Changes in renal dimensions evaluated by magnetic resonance imaging and ultrasonography during long-term ciclosporin-A treatmentGRØN, M. C; KRISTENSEN, D. Hanefelt; CIBULSKYTE, D et al.Acta radiologica (1987). 2006, Vol 47, Num 1, pp 58-64, issn 0284-1851, 7 p.Article